International Clinical Trial: A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129382) titled 'A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis' on Aug. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Chipscreen Biosciences, Ltd.

Condition: Plaque Psoriasis

Intervention: Drug: CS32582 capsule(low dose) or matched placebo Drug: CS32582 capsule(high dose) or matched placebo Drug: CS32582 capsule(low dose) Drug: CS32582 capsule(medium dose) Drug: CS32582 capsu...